Author Index

Search or browse for an author across our entire electronic archive

Search results for: D
Results 921 - 930 of 1402 shown below

  • Dolo, V

    A Ferretti, S D'Ascenzo, A Knijn, E Iorio, V Dolo, A Pavan and F Podo

    Detection of polyol accumulation in a new ovarian carcinoma cell line, CABA I: a1H NMR study

    doi:10.1038/sj.bjc.6600189

    Abstract | Full article | PDF

  • Dolsma, W V

    M Schaapveld, E G E de Vries, R Otter, J de Vries, W V Dolsma and P H B Willemse

    Guideline adherence for early breast cancer before and after introduction of the sentinel node biopsy

    advance online publication, 2005-08-23 00:00:00.000;

    doi:10.1038/sj.bjc.6602747

    Abstract | Full article | PDF

  • Dolz˘an, V

    M C˘emaz˘ar, D Miklavc˘ic˘, J S˘c˘anc˘ar, V Dolz˘an, R Golouh and G Sers˘a

    Increased platinum accumulation in SA-1 tumour cells after in vivo electrochemotherapy with cisplatin

    doi:10.1038/sj.bjc.6690222

    Abstract | Full article | PDF

  • Domènech, M

    O Díez, A Osorio, M Robledo, A Barroso, M Domènech, J Cortés, J Albertos, J Sanz, J Brunet, J M SanRom´n, M C Alonso, M Baiget and J Benítez

    Prevalence of BRCA1 and BRCA2 Jewish mutations in Spanish breast cancer patients

    doi:10.1038/sj.bjc.6690208

    Abstract | Full article | PDF

  • Dombernowsky, P

    U N Lassen, K Østerlind, B Bergman, P Dombernowsky and H H Hansen

    Early death during chemotherapy in patients with small-cell lung cancer: derivation of a prognostic index for toxic death and progression

    doi:10.1038/sj.bjc.6690080

    Abstract | Full article | PDF

  • J B Sørensen, B Bergman, M Krarup, P Dombernowsky and H H Hansen

    Phase II study of gemcitabine and vindesine in patients with previously untreated non-resectable non-small-cell lung cancer

    doi:10.1038/sj.bjc.6690140

    Abstract | Full article | PDF

  • M K Tuxen, G Sölétormos and P Dombernowsky

    Serum tumour marker CA 125 in monitoring of ovarian cancer during first-line chemotherapy

    doi:10.1054/bjoc.2001.1787

    Abstract | Full article | PDF

  • Domchek, S M

    O M Sinilnikova, A C Antoniou, J Simard, S Healey, M Léoné, D Sinnett, A B Spurdle, J Beesley, X Chen, M H Greene, J T Loud, F Lejbkowicz, G Rennert, S Dishon, I L Andrulis, S M Domchek, K L Nathanson, S Manoukian, P Radice, I Konstantopoulou, I Blanco, A L Laborde, M Durán, A Osorio, J Benitez, U Hamann, F B L Hogervorst, T A M van Os, H J P Gille, S Peock, M Cook, C Luccarini, D G Evans, F Lalloo, R Eeles, G Pichert, R Davidson, T Cole, J Cook, J Paterson, C Brewer, D J Hughes, I Coupier, S Giraud, F Coulet, C Colas, F Soubrier, E Rouleau, I Bièche, R Lidereau, L Demange, C Nogues, H T Lynch, R K Schmutzler, B Versmold, C Engel, A Meindl, N Arnold, C Sutter, H Deissler, D Schaefer, U G Froster, K Aittomäki, H Nevanlinna, L McGuffog, D F Easton, G Chenevix-Trench and D Stoppa-Lyonnet

    The TP53 Arg72Pro and MDM2 309G>T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers

    advance online publication, 2009-08-25 00:00:00.000;

    doi:10.1038/sj.bjc.6605279

    Abstract | Full article | PDF

  • A Osorio, R L Milne, G Pita, P Peterlongo, T Heikkinen, J Simard, G Chenevix-Trench, A B Spurdle, J Beesley, X Chen, S Healey, S L Neuhausen, Y C Ding, F J Couch, X Wang, N Lindor, S Manoukian, M Barile, A Viel, L Tizzoni, C I Szabo, L Foretova, M Zikan, K Claes, M H Greene, P Mai, G Rennert, F Lejbkowicz, O Barnett-Griness, I L Andrulis, H Ozcelik, N Weerasooriya, A-M Gerdes, M Thomassen, D G Cruger, M A Caligo, E Friedman, B Kaufman, Y Laitman, S Cohen, T Kontorovich, R Gershoni-Baruch, E Dagan, H Jernström, M S Askmalm, B Arver, B Malmer, S M Domchek, K L Nathanson, J Brunet, T Ramón y Cajal, D Yannoukakos, U Hamann, F B L Hogervorst, S Verhoef, EB Gómez García, J T Wijnen, A van den Ouweland, D F Easton, S Peock, M Cook, C T Oliver, D Frost, C Luccarini, D G Evans, F Lalloo, R Eeles, G Pichert, J Cook, S Hodgson, P J Morrison, F Douglas, A K Godwin, O M Sinilnikova, L Barjhoux, D Stoppa-Lyonnet, V Moncoutier, S Giraud, C Cassini, L Olivier-Faivre, F Révillion, J-P Peyrat, D Muller, J-P Fricker, H T Lynch, E M John, S Buys, M Daly, J L Hopper, M B Terry, A Miron, Y Yassin, D Goldgar, C F Singer, D Gschwantler-Kaulich, G Pfeiler, A-C Spiess, Thomas v O Hansen, O T Johannsson, T Kirchhoff, K Offit, K Kosarin, M Piedmonte, G C Rodriguez, K Wakeley, J F Boggess, J Basil, P E Schwartz, S V Blank, A E Toland, M Montagna, C Casella, E N Imyanitov, A Allavena, R K Schmutzler, B Versmold, C Engel, A Meindl, N Ditsch, N Arnold, D Niederacher, H Deis zligler, B Fiebig, R Varon-Mateeva, D Schaefer, U G Froster, T Caldes, M de la Hoya, L McGuffog, A C Antoniou, H Nevanlinna, P Radice and J Benítez

    Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA)

    advance online publication, 2009-11-17 00:00:00.000;

    doi:10.1038/sj.bjc.6605416

    Abstract | Full article | PDF

  • Domenech, M

    J Carles, A Font, B Mellado, M Domenech, E Gallardo, J L González-Larriba, G Catalan, J Alfaro, A Gonzalez del Alba, M Nogué, P Lianes and J M Tello

    Weekly administration of docetaxel in combination with estramustine and celecoxib in patients with advanced hormone-refractory prostate cancer: final results from a phase II study

    advance online publication, 2007-10-23 00:00:00.000;

    doi:10.1038/sj.bjc.6604030

    Abstract | Full article | PDF

  • Domenge, C

    C Couteau, N Chouaki, S Leyvraz, D Oulid-Aissa, A Lebecq, C Domenge, V Groult, S Bordessoule, F Janot, M De Forni and J-P Armand

    A phase II study of docetaxel in patients with metastatic squamous cell carcinoma of the head and neck

    doi:10.1038/sj.bjc.6690715

    Abstract | Full article | PDF

  • C Domenge, C Hill, J L Lefebvre, D De Raucourt, B Rhein, P Wibault, P Marandas, B Coche-Dequeant, M Stromboni-Luboinski, H Sancho-Garnier and B Luboinski

    Randomized trial of neoadjuvant chemotherapy in oropharyngeal carcinoma

    doi:10.1054/bjoc.2000.1512

    Abstract | Full article | PDF

  • Domenichini, I

    F Cappuzzo, L Toschi, I Domenichini, S Bartolini, G L Ceresoli, E Rossi, V Ludovini, A Cancellieri, E Magrini, L Bemis, W A Franklin, L Crino, P A Bunn, F R Hirsch and M Varella-Garcia

    HER3 genomic gain and sensitivity to gefitinib in advanced non-small-cell lung cancer patients

    advance online publication, 2005-11-15 00:00:00.000;

    doi:10.1038/sj.bjc.6602865

    Abstract | Full article | PDF

  • Domingo-Domenech, J

    J Domingo-Domenech, B Mellado, B Ferrer, D Truan, J Codony-Servat, S Sauleda, J Alcover, E Campo, P Gascon, A Rovira, J S Ross, P L Fernández and J Albanell

    Activation of nuclear factor-kappaB in human prostate carcinogenesis and association to biochemical relapse

    advance online publication, 2005-11-08 00:00:00.000;

    doi:10.1038/sj.bjc.6602851

    Abstract | Full article | PDF